| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 08/02/2006 | CN1812811A Method of reducing the harmful effects of orally or transdermally delivered nicotine |
| 08/01/2006 | US7083572 Therapeutic delivery systems |
| 07/27/2006 | US20060167037 Combinational radiotherapy and chemotherapy compositions and methods |
| 07/27/2006 | US20060167027 Use of the quinazoline derivative zd6474 combined with platinum compounds and optionally ionising radiation in the treatment of diseases associated with angiogenesis and/or increased vascular permeability |
| 07/27/2006 | US20060167024 Cancer combination therapy comprising azd2171 and zd1839 |
| 07/25/2006 | US7081092 Methods and apparatus for monitoring and quantifying the movement of fluid |
| 07/21/2006 | CA2494209A1 Radiosensitizer formulations and methods for use |
| 07/20/2006 | WO2006075678A1 Photosensitive compound |
| 07/20/2006 | US20060159740 Hydrophobic photosensitizer formulations for photodynamic therapy |
| 07/20/2006 | US20060159620 Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent |
| 07/19/2006 | EP1680472A2 Compounds for dual photodiagnosis and therapy |
| 07/19/2006 | EP1680185A2 Phototherapeutic treatment of skin conditions |
| 07/19/2006 | EP1680142A2 Thermosensitive, biocompatible polymer carriers with a variable physical structure for treatment, diagnosis and analysis |
| 07/19/2006 | EP0966481B1 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 07/19/2006 | CN1264577C photodynamic treatment and UV-B irradiation of thrombocyte suspension |
| 07/18/2006 | US7078202 Culture product of yeast cells; applying alternating electric fields; cognition activators |
| 07/18/2006 | US7078015 Temperature activated gaseous liposomes; therapy drug delivery; accumulating in cancer and disease tissue |
| 07/18/2006 | US7078014 In vivo magnetic resonance imaging by intravenous injection of compounds such as porphyrins, chlorins, bacteriochlorins, and related tetra- pyrrolic compounds with radioactive elements such as Technetium99, Gadolinium, Indium111 and iodine |
| 07/13/2006 | WO2003095621A3 Apoptotic ebv-transformed lymphocytes, a therapeutic agent for post-transplant lymphoproliferactive disorder |
| 07/13/2006 | US20060154867 Bacteriophage T7 clone containing a truncated coat p10 and a wild-type tail fiber protein p17 selectively localizes to hepatocytes when injected into a blood vessel in a mammal; T7 p17 protein and drug, component of a drug or polynucleotide complex and polynucleotide |
| 07/13/2006 | CA2593728A1 Magnetoresonance preparations, device for individually selecting said preparations for increasing an organism life activity in actual environmental conditions |
| 07/12/2006 | EP1679077A1 Mucous membrane bulging humor composition comprising chitosan derivative containing saccharide chain for use in condoscopic surgery |
| 07/12/2006 | EP1677826A2 Conjugate of a photosensitiser and a bacteriophage |
| 07/12/2006 | EP1677775A2 Therapeutic use of methionine for the treatment or prevention of mucositis |
| 07/12/2006 | EP1263450A4 Method and apparatus for inducing a cellular response |
| 07/12/2006 | EP0977594B1 Ultrasound imaging of tissue perfusion by pulse energy disruption of contrast agent |
| 07/11/2006 | US7074575 Anticancer activity of IL- 19 polypeptide molecules. IL-19 is a cytokine involved in inflammatory processes and human disease. The present invention includes Use of IL-19 for decreasing proliferation of ovarian cancer cells for ovarian |
| 07/11/2006 | US7074427 Comprises a shell with a gas enclosed in the internal space thereof as well as a substance capable of generating active oxygen species upon irradiation of the shell with an ultrasound as retained or contained in shell; therapy |
| 07/06/2006 | US20060147551 Auxiliary agent to be used in cancer therapy by dielectric heating and cancer therapy method |
| 07/06/2006 | US20060147376 Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier |
| 07/06/2006 | US20060147371 Sustained delivery of chemotherapeutic agent at high concentration without damaging normal cells beyond repair |
| 07/05/2006 | EP1675570A2 Use of photodynamic therapeutic agents entrapped in ceramic nanoparticles |
| 07/04/2006 | US7071163 Compounds for targeting hepatocytes in vivo |
| 07/04/2006 | US7070968 DNA damaging agents in combination with tyrosine kinase inhibitors |
| 07/04/2006 | US7070565 Solid hydrogel coupling for ultrasound imaging and therapy |
| 06/29/2006 | WO2006068187A1 Target physiological function inactivator using photosensitizer-labeled fluorescent protein |
| 06/29/2006 | US20060140912 Methods for enhancing engraftment of purified hematopoietic stem cells in allogeneic recipients |
| 06/29/2006 | CA2591871A1 Target physiological function inactivator using photosensitizer-labeled fluorescent protein |
| 06/28/2006 | EP1673108A2 Methods and compositions for ultrasound imaging of apoptosis |
| 06/28/2006 | CN1261162C Process for preparing aqueous extracts of plants and extracts obtained |
| 06/27/2006 | US7068754 System to generate therapeutic radiation |
| 06/27/2006 | US7067653 Porphyrin Based neuton capture agents for cancer therapy |
| 06/27/2006 | US7066941 Apparatus for skin treatment |
| 06/22/2006 | WO2006064205A2 Process for the preparation of a boron-substituted porphyrin |
| 06/22/2006 | US20060135478 Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof |
| 06/22/2006 | US20060135404 polymer conjugated drug with polylactams; antitumor, anticancer agents for prostate cancer, breast cancer, ovarian cancer, colon cancer, leukemia, and lung cancer; rheumatic diseases; autoimmune diseases |
| 06/22/2006 | CA2591042A1 Process for the preparation of a boron-substituted porphyrin |
| 06/21/2006 | EP1670540A2 Photodynamic inactivation of bacterial spores |
| 06/21/2006 | EP1670512A2 Singlet oxygen photosensitizers activated by target binding enhancing the selectivity of targeted pdt agents |
| 06/15/2006 | US20060129209 Method and apparatus for the stimulation of hair growth |
| 06/15/2006 | US20060128792 Deguelin as a chemopreventive agent for lung cancer |
| 06/15/2006 | US20060128683 Novel use of porphyrin derivatives |
| 06/15/2006 | US20060128672 Methods for the administration of amifostine and related compounds |
| 06/15/2006 | US20060128638 Treating atheroma, tumors and other neoplastic tissue; treating atherosclerotic inflammation; forming a complexes with a reducing agent, penetrate and accumulate more rapidly in tumor cells, plaque, increase drug in intracellular concentration; increase photosensitivity |
| 06/15/2006 | US20060127481 Ophthalmic drug delivery system using polymer micell |
| 06/15/2006 | US20060127349 Administering water soluble complex of hypericin and a polyvinylpyrrolidone; diagnosing and treating tumors |
| 06/15/2006 | US20060127307 Devices and compositions containing boron and silicon for use in neutron capture therapy |
| 06/14/2006 | EP1668424A2 Magnetically targetable particles comprising magnetic components and biocompatible polymers for site-specific delivery of biologically active agents |
| 06/14/2006 | CN1788009A Boronated metal-phthalocyanines, process for their preparation, pharmaceutical compositions comprising them and use thereof |
| 06/14/2006 | CN1787849A Ultrasonic sonophoresis skin care device |
| 06/13/2006 | US7060724 Water soluble paclitaxel derivatives |
| 06/13/2006 | US7060695 Providing, at a frequency of at least about every 45 days during at least a period of three months following an initial photodynamic therapy (PDT), additional PDT treatments to subject after evaluations for neovascular leakage |
| 06/07/2006 | EP1666049A1 Markov therapeutic and preventive compound |
| 06/07/2006 | EP1666018A1 Container for electrically preparing injectable substances |
| 06/07/2006 | EP1663381A1 Sonophoresis skin care device |
| 06/07/2006 | EP1663109A2 Ultrasonic concentration of drug delivery capsules |
| 06/07/2006 | EP1663103A2 Compositions of botanical extracts for cancer therapy |
| 06/06/2006 | US7056491 Sensitizing tumor cells with terpene such as perillyl alcohol |
| 06/06/2006 | CA2171303C Active principles and gas containing microparticles |
| 06/01/2006 | WO2006056227A1 Conjugates comprising the active agent and flanking or branched-chain peptides |
| 06/01/2006 | WO2005117976A3 Method of increasing radiation sensitivity by inhibition of beta one integrin |
| 06/01/2006 | US20060115376 Irradiation in presence of stabilizer; preventing degradation |
| 05/31/2006 | EP1660475A1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/31/2006 | EP1660041A1 Non-polar photosensitizer formulations for photodynamic therapy |
| 05/31/2006 | EP1420824B1 Sulfonated chlorines as photosensitizer |
| 05/31/2006 | EP0885228B1 Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same |
| 05/31/2006 | CN1780632A Therapy for primary and metastatic cancers |
| 05/31/2006 | CN1257712C Photodynamic porphyrin antimicrobial agents |
| 05/30/2006 | US7053072 Methods for the administration of amifostine and related compounds |
| 05/26/2006 | WO2006053707A1 Novel derivatives of porphyrin, particularly chlorins and/or bacteriochlorins, and uses thereof in photodynamic therapy |
| 05/26/2006 | WO2005084754A3 Cancer treatment with topoisomerase-ii inhibitor, a bis-dioxypiperazine and radiation |
| 05/26/2006 | WO2005059118A3 Stem cell targeting using magnetic particles |
| 05/26/2006 | WO2005058360A3 Radiation therapy and medical imaging using uv emitting nanoparticles |
| 05/25/2006 | US20060111335 Photoactivated anti-viral and anti-cancer agent |
| 05/25/2006 | US20060111273 Water soluble paclitaxel derivatives |
| 05/25/2006 | US20060110356 Ophthalmic drug delivery system using polymer micelle |
| 05/24/2006 | EP1658049A2 Ferromagnetic particles and methods |
| 05/24/2006 | EP1453431A4 Method and apparatus for the stimulation of hair growth |
| 05/24/2006 | CN1775315A Method for preventing and reversing atherosclerosis in mammals. |
| 05/23/2006 | US7049110 Inactivation of West Nile virus and malaria using photosensitizers |
| 05/23/2006 | US7048907 Synthesis, compositions and methods for the measurement of the concentration of stable-isotope labeled compounds in life forms and life form excretory products |
| 05/23/2006 | CA2351207C Radionuclide labeling of vitamin b12 and coenzymes thereof |
| 05/18/2006 | WO2006051732A1 Pharmaceutical preparation containing coated magnetic particles and method for production thereof, and diagnosis therapy system |
| 05/18/2006 | WO2006051198A1 Nanoparticles comprising an intracellular targeting element and preparation and use thereof |
| 05/18/2006 | WO2006020979A3 Factor vii conjugates for selectively treating neovascularization disorders |
| 05/18/2006 | WO2005097672A3 Method for the production of carbon nanotubes that are ferromagnetically filled in part and carry biomolecules, and use thereof in diagnosis and therapy |
| 05/18/2006 | US20060106204 Bifunctional energy-reversible acyl-compositions |
| 05/18/2006 | US20060105974 Conjugates of photosensitizers and oligonucleotides for selective photochemiotherapy |
| 05/18/2006 | US20060105961 Method of using a cox-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia |
| 05/18/2006 | US20060105458 Caged tetracycline (derivatives), their generation, and their use for photoactivated gene expression |